Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Eligible Medicare beneficiaries will now have access to GLP-1 drugs through a $50-a-month copay through the Medicare GLP-1 Bridge, a Centers for Medicare & Medicaid Services initiative launched Wednesday
Excess fumarate, resulting from impaired TCA function, accumulates in the cytoplasm and reacts with thiol groups in crucial cellular proteins, leading to succination and inactivation [81, 82]
Wasn't fully characterized until 1935 by Frederick Gowland Hopkins
Key Insights Fatigue is a common but usually temporary side effect during the initial weeks or dose changes in GLP-1 therapy, caused largely by rapid calorie deficit, dehydration, and metabolic adjustments. Maintaining steady energy requires prioritising nutrient-dense meals rich in protein and complex carbohydrates, staying well hydrated, and managing electrolyte balance, which helps mitigate tiredness and supports overall metabolism. Gentle physical activity and good sleep hygiene are critical lifestyle adjustments that improve circulation, mood, and energy levels without overtaxing the body during the drug adaptation period. Persistent, worsening, or debilitating fatigue should prompt medical evaluation to exclude other causes, reassess medication dosing, and ensure safe continuation of GLP-1 therapy under healthcare supervision. Frequently asked questions Why do GLP-1 medications cause fatigue
For athletes who lose training days to illness after hard blocks, maintaining glutathione levels helps keep your immune system strong when it's most suppressed
